SIGN UP
LOG IN
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Benzinga·06/02/2025 11:29:14
Listen to the news
Shares of Blueprint Medicines Corporation (NASDAQ:BPMC) rose sharply in today's pre-market trading.
Sanofi SA (NASDAQ:SNY) announced plans to acquire Blueprint Medicines for $9.5 billion.
Blueprint Medicines shares jumped 26.9% to $128.62 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Lyra Therapeutics, Inc. (NASDAQ:LYRA) shares jumped 199% to $14.74 in pre-market trading after the company reported positive results from the ENLIGHTEN 2 Phase 3 trial of LYR-210 achieving statistically significant results for primary and key secondary endpoints in the treatment of Chronic Rhinosinusitis (CRS).
- InMed Pharmaceuticals Inc. (NASDAQ:INM) rose 93.2% to $4.81 in pre-market trading.
- Vera Therapeutics, Inc. (NASDAQ:VERA) surged 69% to $32.02 in pre-market trading after the company said Atacicept ORIGIN Phase 3 trial met primary endpoint of reduction in UPCR for IgAN treatment.
- Brand Engagement Network, Inc. (NASDAQ:BNAI) jumped 68.5% to $0.47 in pre-market trading after gaining 13% on Friday.
- Basel Medical Group Ltd (NASDAQ:BMGL) surged 51.4% to $9.20 in pre-market trading after jumping 485% on Friday.
- Black Spade Acquisition II Co (NASDAQ:BSII) gained 37.3% to $13.29 in pre-market trading after falling 5% on Friday.
- DigiAsia Corp. (NASDAQ:FAAS) climbed 27.7% to $1.6990 in pre-market trading after jumping 24% on Friday.
- Cleveland-Cliffs Inc. (NYSE:CLF) rose 25.6% to $7.32 in pre-market trading.
- BioNTech SE (NASDAQ:BNTX) gained 14.1% to $109.32 in pre-market trading. BioNTech and Bristol Myers Squibb announced a global strategic partnership to co-develop and co-commercialize next-generation bispecific antibody candidate BNT327 broadly for multiple solid tumor types
Losers
- ReShape Lifesciences Inc. (NASDAQ:RSLS) shares dipped 23.2% to $3.77 in pre-market trading. ReShape Lifesciences entered into equity distribution agreement relating to sale of up to $9.7 million of shares of common stock.
- China Liberal Education Holdings Limited (NASDAQ:CLEU) shares fell 22.6% to $0.7500 in pre-market trading after the company announced suspension of Nasdaq trading.
- Silexion Therapeutics Corp (NASDAQ:SLXN) fell 20.2% to $0.8300 in pre-market trading after gaining 8% on Friday.
- SharpLink Gaming, Inc. (NASDAQ:SBET) declined 18.4% to $62.60 in pre-market trading after the company filed for mixed shelf offering.
- ContextLogic Inc. (NASDAQ:LOGC) shares tumbled 18.3% to $6.70 in pre-market trading. ContextLogic will commence trading on the OTC Markets and delist from the Nasdaq.
- Xilio Therapeutics, Inc. (NASDAQ:XLO) fell 17.9% to $0.8788 in pre-market trading after the company announced a proposed public offering.
- Super League Enterprise, Inc. (NASDAQ:SLE) fell 16.4% to $0.1629 in today's pre-market trading. Super League Enterprise, on Friday, announced a registered direct offering.
- Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) dipped 16% to $1.68 in pre-market trading. TIAN RUIXIANG shares gained 8% on Friday after the company announced plans to buy Ucare for $150 million in an all-stock deal.
- Lucid Diagnostics Inc. (NASDAQ:LUCD) shares fell 15.1% to $1.18 in pre-market trading. Lucid Diagnostics may offer sell shares of common stock of up to $25 MILLION.
- Algoma Steel Group Inc. (NASDAQ:ASTL) fell 9.2% to $4.78 in pre-market trading.
Now Read This:
- Wall Street’s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.